Fig. 12

Numbers and relative percentages of papers from projects on AD, BC and PC with clinical trials (A) and that considered patient stratification (B) across framework programmes (FP5, FP6, FP7 and H2020) that accounted for the use of animals alone or in combination with other non-animal methods (orange bars) or based exclusively on non-animal methods and technologies (green bars). Y axis reports percentage values, whilst absolute numbers of papers are reported inside bars